Receptor binding and electrophysiological effects of dehydroepiandrosterone sulfate, an antagonist of the GABAA receptor.

PubWeight™: 1.04‹?› | Rank: Top 15%

🔗 View Article (PMID 1661387)

Published in Neuroscience on January 01, 1991

Authors

S Demirgören1, M D Majewska, C E Spivak, E D London

Author Affiliations

1: Neuropharmacology Laboratory, National Institute on Drug Abuse, Baltimore, MD 21224.

Articles citing this

Pregnenolone sulfate block of GABA(A) receptors: mechanism and involvement of a residue in the M2 region of the alpha subunit. J Physiol (2001) 1.54

Neurosteroids, via sigma receptors, modulate the [3H]norepinephrine release evoked by N-methyl-D-aspartate in the rat hippocampus. Proc Natl Acad Sci U S A (1995) 1.43

Reproductive hormone sensitivity and risk for depression across the female life cycle: a continuum of vulnerability? J Psychiatry Neurosci (2008) 1.13

Mitotic and neurogenic effects of dehydroepiandrosterone (DHEA) on human neural stem cell cultures derived from the fetal cortex. Proc Natl Acad Sci U S A (2004) 1.10

Pancreatic exocrine and endocrine function after operations for chronic pancreatitis. Ann Surg (1992) 1.02

Cis-isomerism and other chemical requirements of steroidal agonists and partial agonists acting at TRPM3 channels. Br J Pharmacol (2010) 0.92

The influence of the membrane on neurosteroid actions at GABA(A) receptors. Psychoneuroendocrinology (2009) 0.91

Discriminative stimulus effects of ethanol, pregnanolone, and dehydroepiandrosterone (DHEA) in rats administered ethanol or saline as adolescents. Pharmacol Biochem Behav (2009) 0.87

The relevance of neuroactive steroids in schizophrenia, depression, and anxiety disorders. Cell Mol Neurobiol (2007) 0.87

Active sulforhodamine 101 uptake into hippocampal astrocytes. PLoS One (2012) 0.86

Photoperiodic modulation of adrenal gland function in the rhesus macaque: effect on 24-h plasma cortisol and dehydroepiandrosterone sulfate rhythms and adrenal gland gene expression. J Endocrinol (2009) 0.84

Neurosteroids and GABA-A Receptor Function. Front Endocrinol (Lausanne) (2011) 0.82

Effects of methylphenidate and bupropion on DHEA-S and cortisol plasma levels in attention-deficit hyperactivity disorder. Child Psychiatry Hum Dev (2007) 0.81

Intrathecal injection of the neurosteroid, DHEAS, produces mechanical allodynia in mice: involvement of spinal sigma-1 and GABA receptors. Br J Pharmacol (2009) 0.81

Reactive oxygen species initiate a metabolic collapse in hippocampal slices: potential trigger of cortical spreading depression. J Cereb Blood Flow Metab (2014) 0.78

Effects of chronic alcohol consumption on neuronal function in the non-human primate BNST. Addict Biol (2015) 0.76

Novel dehydroepiandrosterone troche supplementation improves the serum androgen profile of women undergoing in vitro fertilization. Drug Des Devel Ther (2015) 0.75

Acute Effects of Oral Dehydroepiandrosterone on Counterregulatory Responses During Repeated Hypoglycemia in Healthy Humans. Diabetes (2016) 0.75

Depression, Anxiety, and Anger in Patients with Polycystic Ovary Syndrome. Noro Psikiyatr Ars (2014) 0.75

Effects of acute and chronic administration of neurosteroid dehydroepiandrosterone sulfate on neuronal excitability in mice. Drug Des Devel Ther (2016) 0.75

Effects of dehydroepiandrosterone sulfate on the evoked cortical activity of controls and of brain-injured rats. Cell Mol Neurobiol (2006) 0.75

Articles by these authors

Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc Natl Acad Sci U S A (1991) 5.70

Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science (1986) 4.44

Activation of memory circuits during cue-elicited cocaine craving. Proc Natl Acad Sci U S A (1996) 4.31

Gender-linked brain injury in experimental stroke. Stroke (1998) 3.08

Steroid binding at sigma receptors suggests a link between endocrine, nervous, and immune systems. Science (1988) 3.01

Drug abusers show impaired performance in a laboratory test of decision making. Neuropsychologia (2000) 2.82

Orbitofrontal cortex dysfunction in abstinent cocaine abusers performing a decision-making task. Neuroimage (2003) 2.75

Phenomics: the systematic study of phenotypes on a genome-wide scale. Neuroscience (2009) 2.38

Fractal models are inadequate for the kinetics of four different ion channels. Biophys J (1988) 2.06

Structure-activity relationships for steroid interaction with the gamma-aminobutyric acidA receptor complex. J Pharmacol Exp Ther (1987) 2.01

Higher levels of nicotine in arterial than in venous blood after cigarette smoking. Drug Alcohol Depend (1993) 1.84

5-Iodo-A-85380, an alpha4beta2 subtype-selective ligand for nicotinic acetylcholine receptors. Mol Pharmacol (2000) 1.67

Smoking history and nicotine effects on cognitive performance. Neuropsychopharmacology (2001) 1.61

17beta-estradiol reduces stroke injury in estrogen-deficient female animals. Stroke (1999) 1.58

The neurosteroid dehydroepiandrosterone sulfate is an allosteric antagonist of the GABAA receptor. Brain Res (1990) 1.48

Effects of nitrous oxide and halothane on mu and kappa opioid receptors in guinea-pig brain. Anesthesiology (1989) 1.47

Smaller volume of prefrontal lobe in polysubstance abusers: a magnetic resonance imaging study. Neuropsychopharmacology (1998) 1.46

Effect of nicotine on brain activation during performance of a working memory task. Proc Natl Acad Sci U S A (2001) 1.41

mu opiate receptor: cDNA cloning and expression. Proc Natl Acad Sci U S A (1993) 1.39

The neuropsychiatry of chronic cocaine abuse. J Neuropsychiatry Clin Neurosci (1998) 1.38

Pregnenolone-sulfate: an endogenous antagonist of the gamma-aminobutyric acid receptor complex in brain? Brain Res (1987) 1.37

Potential adverse effects of amphetamine treatment on brain and behavior: a review. Mol Psychiatry (2008) 1.25

Specific binding of [3H]kainic acid to receptor sites in rat brain. Mol Pharmacol (1979) 1.21

Abstinence from cocaine reduces high-risk responses on a gambling task. Neuropsychopharmacology (2000) 1.20

Structural and electronic requirements for potent agonists at a nicotinic receptor. Eur J Pharmacol (1986) 1.16

Anxiolytic activity of an endogenous adrenal steroid. Brain Res (1986) 1.12

Pharmacology of GABA rho 1 and GABA alpha/beta receptors expressed in Xenopus oocytes and COS cells. Br J Pharmacol (1993) 1.09

Cerebral glucose utilization, as measured with positron emission tomography in 21 resting healthy men between the ages of 21 and 83 years. Brain (1983) 1.08

Supraphysiological doses of levothyroxine alter regional cerebral metabolism and improve mood in bipolar depression. Mol Psychiatry (2005) 1.08

Changes in cerebral glucose metabolism during early abstinence from chronic methamphetamine abuse. Mol Psychiatry (2007) 1.05

2-, 5-, and 6-Halo-3-(2(S)-azetidinylmethoxy)pyridines: synthesis, affinity for nicotinic acetylcholine receptors, and molecular modeling. J Med Chem (1998) 1.04

Regulation of the NMDA receptor by redox phenomena: inhibitory role of ascorbate. Brain Res (1990) 1.03

Rapid effects of brief intensive cognitive-behavioral therapy on brain glucose metabolism in obsessive-compulsive disorder. Mol Psychiatry (2008) 1.01

Fractal models, Markov models, and channel kinetics. Biophys J (1989) 1.01

Mutagenesis of the GABA rho 1 receptor alters agonist affinity and channel gating. Neuroreport (1994) 1.00

Potent sigma1-receptor ligand 4-phenyl-1-(4-phenylbutyl) piperidine modulates basal and N-methyl-D-aspartate-evoked nitric oxide production in vivo. Stroke (1998) 0.98

Differential effects of age on motor performance in two mouse strains. Neurobiol Aging (1981) 0.98

Development of ligands for in vivo imaging of cerebral nicotinic receptors. Behav Brain Res (2000) 0.98

2-[18F]Fluoro-A-85380, an in vivo tracer for the nicotinic acetylcholine receptors. Nucl Med Biol (1998) 0.98

Sex difference in up-regulation of nicotinic acetylcholine receptors in rat brain. Life Sci (1997) 0.97

[125I]IPH, an epibatidine analog, binds with high affinity to neuronal nicotinic cholinergic receptors. J Pharmacol Exp Ther (1997) 0.95

Subjective and cardiovascular effects of intravenous nicotine in smokers and non-smokers. Psychopharmacology (Berl) (1996) 0.95

Cerebral glucose utilization in polysubstance abuse. Neuropsychopharmacology (1995) 0.94

Radial maze performance in young and aged mice: neurochemical correlates. Pharmacol Biochem Behav (1985) 0.94

Anatoxin-a: a novel, potent agonist at the nicotinic receptor. Mol Pharmacol (1980) 0.94

Further characterization of [3H]ifenprodil binding to sigma receptors in rat brain. Eur J Pharmacol (1993) 0.94

Autoradiographic localization of [3H]nicotine binding sites in the rat brain. Neurosci Lett (1985) 0.94

sigma(1)-receptor ligand 4-phenyl-1-(4-phenylbutyl)-piperidine affords neuroprotection from focal ischemia with prolonged reperfusion. Stroke (2000) 0.93

PPBP [4-phenyl-1-(4-phenylbutyl) piperidine] decreases brain injury after transient focal ischemia in rats. Stroke (1996) 0.93

Effects of L-cocaine on local cerebral glucose utilization in the rat. Neurosci Lett (1986) 0.92

Impaired learning in rats in a 14-unit T-maze by 7-nitroindazole, a neuronal nitric oxide synthase inhibitor, is attenuated by the nitric oxide donor, molsidomine. Eur J Pharmacol (1998) 0.91

6-[18F]fluoro-A-85380, a novel radioligand for in vivo imaging of central nicotinic acetylcholine receptors. Life Sci (2000) 0.91

Glucocorticoids are modulators of GABAA receptors in brain. Brain Res (1985) 0.91

Brain glucose metabolism in hypothyroidism: a positron emission tomography study before and after thyroid hormone replacement therapy. J Clin Endocrinol Metab (2009) 0.90

Effect of ischemic anoxia and barbiturate anesthesia on free radical oxidation of mitochondrial phospholipids. Brain Res (1978) 0.90

Alterations in local cerebral glucose utilization induced by phencyclidine. Brain Res (1987) 0.90

In vivo imaging of brain nicotinic acetylcholine receptors with 5-[123I]iodo-A-85380 using single photon emission computed tomography. Life Sci (1998) 0.90

Aging and caloric restriction in nonhuman primates: behavioral and in vivo brain imaging studies. Ann N Y Acad Sci (2001) 0.90

Synthesis, pharmacology, and molecular modeling studies of semirigid, nicotinic agonists. J Med Chem (1988) 0.90

Reduced density of NMDA receptors and increased sensitivity to dizocilpine-induced learning impairment in aged rats. Brain Res (1992) 0.89

Further in vivo studies on attenuating morphine withdrawal: isoform-selective nitric oxide synthase inhibitors differ in efficacy. Eur J Pharmacol (1997) 0.89

Age-related decline in striatal volume in monkeys as measured by magnetic resonance imaging. Neurobiol Aging (2000) 0.89

PPBP [4-phenyl-1-(4-phenylbutyl) piperidine], a potent sigma-receptor ligand, decreases brain injury after transient focal ischemia in cats. Stroke (1995) 0.89

Sigma receptors in post-mortem human brains. J Pharmacol Exp Ther (1988) 0.89

In vivo studies with [125I]5-I-A-85380, a nicotinic acetylcholine receptor radioligand. Neuroreport (1998) 0.89

High affinity binding of [3H]epibatidine to rat brain membranes. Neuroreport (1999) 0.88

Decreased receptor-binding sites for kainic acid in brains of patients with Huntington's disease. Biol Psychiatry (1981) 0.88

Selective loss of cerebral cortical sigma, but not PCP binding sites in schizophrenia. Biol Psychiatry (1991) 0.88

No effect of hyperketonemia on local cerebral glucose utilization in conscious rats. J Neurochem (1982) 0.88

Rodent models of memory dysfunction in Alzheimer's disease and normal aging: moving beyond the cholinergic hypothesis. Life Sci (1994) 0.88

Sleep induction by an adrenal steroid in the rat. Psychopharmacology (Berl) (1987) 0.87

Postischemic brain injury is affected stereospecifically by pentazocine in rats. Anesth Analg (1997) 0.87

Thyroid, brain and mood modulation in affective disorder: insights from molecular research and functional brain imaging. Pharmacopsychiatry (2003) 0.87

Loss of D2 receptor binding with age in rhesus monkeys: importance of correction for differences in striatal size. J Cereb Blood Flow Metab (1999) 0.86

Comparison of 7-nitroindazole with other nitric oxide synthase inhibitors as attenuators of opioid withdrawal. Psychopharmacology (Berl) (1995) 0.86

Aging alters the circadian rhythm of glucose utilization in the suprachiasmatic nucleus. Proc Natl Acad Sci U S A (1988) 0.86

Neuroprotection from focal ischemia by 4-phenyl-1-(4-phenylbutyl) piperidine (PPBP) is dependent on treatment duration in rats. Anesth Analg (1998) 0.85

[AIDS and sleep disorders: effect of gp120 on cerebral glucose metabolism]. C R Seances Soc Biol Fil (1989) 0.85

Imaging nicotinic acetylcholine receptors with fluorine-18-FPH, an epibatidine analog. J Nucl Med (1997) 0.84

New pharmacological strategies for cognitive enhancement using a rat model of age-related memory impairment. Ann N Y Acad Sci (1994) 0.84

Further characterization of [3H]ifenprodil binding in rat brain. Eur J Pharmacol (1994) 0.84

Effects of triazolam on brain activity during episodic memory encoding: a PET study. Neuropsychopharmacology (2001) 0.84

Learning in a 14-unit T-maze is impaired in rats following systemic treatment with N omega-nitro-L-arginine. Eur J Pharmacol (1998) 0.83

In vivo labeling of sigma receptors in mouse brain with [3H]4-phenyl-1-(4-phenylbutyl)piperidine. Synapse (1995) 0.83

Electrophysiological and binding studies on intact NCB-20 cells suggest presence of a low affinity sigma receptor. J Pharmacol Exp Ther (1991) 0.83

Dietary restriction suppresses age-related changes in dendritic spines. Neurobiol Aging (1989) 0.83

Triphenylmethylphosphonium blocks the nicotinic acetylcholine receptor noncompetitively. Mol Pharmacol (1985) 0.83

Binding of pregnenolone sulfate to rat brain membranes suggests multiple sites of steroid action at the GABAA receptor. Eur J Pharmacol (1990) 0.83

Autoradiographic evidence that prolonged withdrawal from intermittent cocaine reduces mu-opioid receptor expression in limbic regions of the rat brain. Synapse (2000) 0.83

Effects of morphine on the phenotypic expression of cell surface markers on murine lymphocytes. Life Sci (1992) 0.83

Dopamine D2/D3 receptor availability in genetically leptin-deficient patients after long-term leptin replacement. Mol Psychiatry (2011) 0.82

Isoarecolone can inhibit nicotine binding and produce nicotine-like discriminative stimulus effects in rats. Neuropharmacology (1987) 0.82

Altered cerebral glucose utilization following blood-brain barrier opening by hypertonicity or hypertension. Exp Neurol (1981) 0.82

Cerebral glucose utilization is reduced in second test session. J Cereb Blood Flow Metab (1997) 0.82

Phylogenetic distribution of [3H]kainic acid receptor binding sites in neuronal tissue. Brain Res (1980) 0.82

Age and neurochemical correlates of radial maze performance in rats. Neurobiol Aging (1981) 0.82

Actions of the histrionicotoxins at the ion channel of the nicotinic acetylcholine receptor and at the voltage-sensitive ion channels of muscle membranes. Mol Pharmacol (1982) 0.82

Morphine decreases cerebral glucose utilization in limbic and forebrain regions while pain has no effect. Neuropharmacology (1991) 0.81